Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTSG | P08311 | 1/20 | 0.56 |
| ▸ | CTSA | P10619 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | MTOR | P42345 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24891350 | 0.88 | ELANE (0.61) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL29391754 | 0.85 | ALDH1A1 (0.58) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL30966887 | 0.85 | ALDH1A1 (0.58) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL257 | 0.85 | ALDH1A1 (0.58) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL8958450 | 0.85 | KDM4E (0.62) | ALDH1A1SMN1; SMN2MAPTLMNAHSD17B10 | |
| SCHEMBL28252904 | 0.82 | NPSR1 (0.57) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL29599746 | 0.82 | NPSR1 (0.57) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL20963057 | 0.81 | ELANE (0.54) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL30880452 | 0.80 | ESR2 (0.57) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT | |
| SCHEMBL21173973 | 0.79 | ELANE (0.52) | ELANEALDH1A1SMN1; SMN2NPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BASF SE (DE) | 2026-04-28 | — | — | US | disclosed |
| CN-113330086-B | curable composition | 巴斯夫欧洲公司 | 2023-11-03 | — | — | CN | disclosed |
| US-20230012924-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2023-01-19 | — | — | US | disclosed |
| US-20220380591-A1 | CURABLE COMPOSITIONS WITH ACRYLIC AND SILICONE RESINS | BASF SE (DE) | 2022-12-01 | — | — | US | disclosed |
| EP-4077405-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2022-10-26 | — | — | EP | disclosed |
| EP-4034601-A1 | CURABLE COMPOSITIONS WITH ACRYLIC AND SILICONE RESINS | BASF SE (DE) | 2022-08-03 | — | — | EP | disclosed |
| US-20210403772-A1 | CURABLE ADHESIVE COMPOSITION | BASF SE (DE) | 2021-12-30 | — | — | US | disclosed |
| EP-3880764-A2 | CURABLE COMPOSITION | BASF SE (DE) | 2021-09-22 | — | — | EP | disclosed |
| WO-2021126780-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021061533-A1 | CURABLE COMPOSITIONS WITH ACRYLIC AND SILICONE RESINS | BASF SE (DE) | 2021-04-01 | — | — | WO | disclosed |
| WO-2020102801-A2 | CURABLE COMPOSITION | BASF SE (DE) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612482-B2 | Combination of crosslinkers to improve coating properties | BHMT2, FDFT1, MNAT1 | ELANE 3647/4885ALDH1A1 619/4885SMN1; SMN2 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.